GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Amgen Inc. rose $4.04 or 2.5 percent, to $163.48. Biogen Idec rose $7.76 or 2.4 percent, to $332.89. Celgene Corp. rose $2.73 or 2.5 percent, to $112.82.

  • Midday Glance: Biotechnology companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    Amgen Inc. rose $1.41 or. 9 percent, to $160.85. Biogen Idec rose $2.00 or. 6 percent, to $327.13. Celgene Corp. rose$. 63 or. 6 percent, to $110.72.

  • Early Glance: Biotechnology companies Wednesday, 17 Dec 2014 | 10:16 AM ET

    Amgen Inc. rose $1.19 or. 7 percent, to $160.63. Biogen Idec fell$. 02 or percent, to $325.11. Celgene Corp. rose$. 26 or. 2 percent, to $110.35.

  • Final Glance: Biotechnology companies Tuesday, 16 Dec 2014 | 6:41 PM ET

    Amgen Inc. fell$. 16 or. 1 percent, to $159.44. Biogen Idec fell $10.67 or 3.2 percent, to $325.13. Celgene Corp. fell $1.79 or 1.6 percent, to $110.09.

  • Midday Glance: Biotechnology companies Tuesday, 16 Dec 2014 | 1:20 PM ET

    Amgen Inc. rose $2.63 or 1.6 percent, to $162.23. Biogen Idec fell $2.99 or. 9 percent, to $332.81. Celgene Corp. rose$. 30 or. 3 percent, to $112.18.

  • Early Glance: Biotechnology companies Tuesday, 16 Dec 2014 | 10:20 AM ET

    Amgen Inc. rose$. 39 or. 2 percent, to $159.99. Biogen Idec rose$. 70 or. 2 percent, to $336.50. Celgene Corp. fell $1.53 or 1.4 percent, to $110.35.

  • Final Glance: Biotechnology companies Monday, 15 Dec 2014 | 6:08 PM ET

    Amgen Inc. fell $4.93 or 3.0 percent, to $159.60. Biogen Idec fell $8.69 or 2.5 percent, to $335.80. Celgene Corp. fell $2.61 or 2.3 percent, to $111.88.

  • Midday Glance: Biotechnology companies Monday, 15 Dec 2014 | 1:43 PM ET

    Amgen Inc. fell $3.39 or 2.1 percent, to $161.14. Biogen Idec fell $5.90 or 1.7 percent, to $338.59. Celgene Corp. fell $1.30 or 1.1 percent, to $113.19.

  • Early Glance: Biotechnology companies Monday, 15 Dec 2014 | 12:00 PM ET

    Amgen Inc. fell $1.94 or 1.2 percent, to $162.60. Biogen Idec fell$. 44 or. 1 percent, to $344.05. Celgene Corp. rose$. 47 or. 4 percent, to $114.96.

  • Final Glance: Biotechnology companies Friday, 12 Dec 2014 | 6:03 PM ET

    Amgen Inc. fell $1.55 or. 9 percent, to $164.53. Biogen Idec rose $2.16 or. 6 percent, to $344.49. Celgene Corp. fell $2.25 or 1.9 percent, to $114.49.

  • Midday Glance: Biotechnology companies Friday, 12 Dec 2014 | 1:18 PM ET

    Amgen Inc. rose$. 25 or. 1 percent, to $166.33. Biogen Idec rose $1.12 or. 3 percent, to $343.45. Celgene Corp. fell$. 99 or. 8 percent, to $115.75.

  • Early Glance: Biotechnology companies Friday, 12 Dec 2014 | 10:31 AM ET

    Amgen Inc. rose$. 24 or. 1 percent, to $166.32. Biogen Idec rose $3.18 or. 9 percent, to $345.51. Celgene Corp. fell$. 17 or. 1 percent, to $116.57.

  • Final Glance: Biotechnology companies Thursday, 11 Dec 2014 | 6:02 PM ET

    Amgen Inc. rose$. 69 or. 4 percent, to $166.08. Biogen Idec fell $1.26 or. 4 percent, to $342.33. Celgene Corp. rose $1.10 or 1.0 percent, to $116.74.

  • Midday Glance: Biotechnology companies Thursday, 11 Dec 2014 | 1:18 PM ET

    Amgen Inc. rose $2.69 or 1.6 percent, to $168.08. Biogen Idec rose $3.88 or 1.1 percent, to $347.47. Celgene Corp. rose $2.16 or 1.9 percent, to $117.80.

  • Early Glance: Biotechnology companies Thursday, 11 Dec 2014 | 11:28 AM ET

    Amgen Inc. rose $2.53 or 1.5 percent, to $167.92. Biogen Idec rose $2.90 or. 8 percent, to $346.49. Celgene Corp. rose $1.91 or 1.7 percent, to $117.55.

  • Final Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Amgen Inc. fell $4.00 or 2.4 percent, to $165.39. Biogen Idec fell $4.02 or 1.2 percent, to $343.59. Celgene Corp. fell $3.04 or 2.6 percent, to $115.64.

  • Gilead faces lawsuit over hepatitis C drug pricing Wednesday, 10 Dec 2014 | 5:59 PM ET

    HAVERFORD, Pa.— Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences Inc. over the pricing of its hepatitis C drug. Gilead has been selling a 12- week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill. The Foster City, California, company could not be reached immediately for a comment...

  • Gilead sued over 'exorbitant' hepatitis C drug prices Wednesday, 10 Dec 2014 | 3:55 PM ET

    Dec 10- Philadelphia's transportation authority has filed a class action lawsuit accusing Gilead Sciences Inc of charging "exorbitant" prices for its blockbuster hepatitis C drug Sovaldi. The lawsuit, filed Tuesday in federal court in Philadelphia by the Southeastern Pennsylvania Transportation Authority, seeks an unspecified amount of money damages.

  • Midday Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Amgen Inc. fell $1.19 or. 7 percent, to $168.20. Biogen Idec fell $1.82 or. 5 percent, to $345.79. Celgene Corp. fell$. 97 or. 8 percent, to $117.71.

  • Early Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Amgen Inc. rose$. 07 or percent, to $169.46. Biogen Idec fell$. 17 or percent, to $347.44. Celgene Corp. fell$. 39 or. 3 percent, to $118.29.